Experiment: 8FG1

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D CBCA(CO)NH	300 uM [U-100% 13C; U-100% 15N] Diaphanous inhibitory domain, 500 uM Diaphanous autoregulatory domain	90% H2O/10% D2O	140 mM	7.5	1 atm	305	Bruker Ascend 600
2	3D HNCO	300 uM [U-100% 13C; U-100% 15N] Diaphanous inhibitory domain, 500 uM Diaphanous autoregulatory domain	90% H2O/10% D2O	140 mM	7.5	1 atm	305	Bruker Ascend 600
3	3D HNCA	300 uM [U-100% 13C; U-100% 15N] Diaphanous inhibitory domain, 500 uM Diaphanous autoregulatory domain	90% H2O/10% D2O	140 mM	7.5	1 atm	305	Bruker Ascend 600
4	3D HNCACB	300 uM [U-100% 13C; U-100% 15N] Diaphanous inhibitory domain, 500 uM Diaphanous autoregulatory domain	90% H2O/10% D2O	140 mM	7.5	1 atm	305	Bruker Ascend 600
5	3D HN(CO)CA	300 uM [U-100% 13C; U-100% 15N] Diaphanous inhibitory domain, 500 uM Diaphanous autoregulatory domain	90% H2O/10% D2O	140 mM	7.5	1 atm	305	Bruker Ascend 600
14	3D H(CCO)NH	300 uM [U-100% 13C; U-100% 15N] Diaphanous inhibitory domain, 500 uM Diaphanous autoregulatory domain	90% H2O/10% D2O	140 mM	7.5	1 atm	305	Bruker Ascend 600
9	3D 1H-15N NOESY	300 uM [U-15N] Diaphanous inhibitory domain, 500 uM Diaphanous autoregulatory domain	90% H2O/10% D2O	140 mM	7.5	1 atm	305	Bruker Ascend 600
8	3D 1H-15N NOESY	300 uM [U-15N] Diaphanous inhibitory domain, 500 uM [U-13C] Diaphanous autoregulatory domain	90% H2O/10% D2O	140 mM	7.5	1 atm	305	Bruker Ascend 600
7	3D 1H-15N NOESY	300 uM Diaphanous inhibitory domain, 300 uM [U-100% 15N] Diaphanous autoregulatory domain	90% H2O/10% D2O	140 mM	7.5	1 atm	305	Bruker Ascend 600
6	2D 1H-15N HSQC	300 uM [U-15N] Diaphanous inhibitory domain, 500 uM Diaphanous autoregulatory domain	90% H2O/10% D2O	140 mM	7.5	1 atm	305	Bruker Ascend 600
11	2D 1H-15N HSQC	300 uM Diaphanous inhibitory domain, 300 uM [U-100% 15N] Diaphanous autoregulatory domain	90% H2O/10% D2O	140 mM	7.5	1 atm	305	Bruker Ascend 600
10	3D HNCA	300 uM Diaphanous inhibitory domain, 500 uM [U-100% 13C; U-100% 15N] Diaphanous autoregulatory domain	90% H2O/10% D2O	140 mM	7.5	1 atm	305	Bruker Ascend 600
13	3D HNCACB	300 uM Diaphanous inhibitory domain, 500 uM [U-100% 13C; U-100% 15N] Diaphanous autoregulatory domain	90% H2O/10% D2O	140 mM	7.5	1 atm	305	Bruker Ascend 600
12	3D HN(CO)CA	300 uM Diaphanous inhibitory domain, 500 uM [U-100% 13C; U-100% 15N] Diaphanous autoregulatory domain	90% H2O/10% D2O	140 mM	7.5	1 atm	305	Bruker Ascend 600
15	3D HBHA(CO)NH	300 uM Diaphanous inhibitory domain, 500 uM [U-100% 13C; U-100% 15N] Diaphanous autoregulatory domain	90% H2O/10% D2O	140 mM	7.5	1 atm	305	Bruker Ascend 600
16	H(CCH)-TOCSY	300 uM Diaphanous inhibitory domain, 500 uM [U-100% 13C; U-100% 15N] Diaphanous autoregulatory domain	90% H2O/10% D2O	140 mM	7.5	1 atm	305	Bruker Ascend 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	Ascend	600

NMR Refinement
Method	Details	Software
molecular dynamics		YASARA

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	200
Conformers Submitted Total Number	20
Representative Model	1 (fewest violations)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin		Bruker Biospin
2	processing	TopSpin		Bruker Biospin
3	chemical shift assignment	CARA		Keller and Wuthrich
4	peak picking	CARA		Keller and Wuthrich
5	structure calculation	CYANA		Guntert, Mumenthaler and Wuthrich
6	refinement	YASARA		Krieger

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.